蘑菇AV

Healthcare and pharma companies are embracing D2C business models to get their medications, treatments, and services to more consumers without industry middlemen restricting access. Concurrently, patients are becoming more price-conscious healthcare shoppers, propelling more D2C activity next year.

Senators reintroduce Drug-price Transparency for Consumers Act: If passed, the Act could empower patients to make informed decisions about their healthcare amid a torrent of direct-to-consumer drug ads.

Healthcare and pharma companies will lean further into D2C in 2025: They鈥檙e cutting out health insurers and PBMs that bottleneck patient access to their products and services. But the industry鈥檚 push into D2C won鈥檛 be met without challenges.

The battle between Big Pharma and D2C weight loss drug sellers will intensify in 2025: We explore the competitive GLP-1 drug market and detail what鈥檚 at stake for drugmakers and D2C companies selling compounded weight loss medications.

Sanofi鈥檚 Opella secures FDA nod to pursue OTC Cialis study: If Cialis鈥� shift from a prescription drug to over-the-counter product comes to fruition, both consumers and D2C retailers could benefit.

Could Trump鈥檚 second term include a ban on D2C pharma ads? We examine the likelihood of a ban and explore what more oversight of drug ads on TV means for pharma marketers.

RFK Jr.鈥檚 pharmaceutical ad ban could affect $22 billion in ad spending: A business-friendly Trump administration could hamper RFK鈥檚 plans to cut D2C advertising.

Nike's recent struggles highlight the risks of an ill-timed shift to direct-to-consumer (D2C) sales. The sportswear giant's sales slumped 10% YoY for the quarter ending August 31 as competitors gained market share.

Hims to offer a generic GLP-1 in 2025: It鈥檚 preparing for headwinds if the FDA halts compounded versions of weight loss drugs. But we think its diverse D2C offerings and strong subscriber growth should help insulate it financially.

Walgreens expands D2C telehealth to 30 states: We examine how the move aligns with Walgreens鈥� strategy to rightsize its retail pharmacy business.

On Holdings鈥檚 sales jumped 34% in Q3: The upstart鈥檚 efforts to boost brand awareness gave lucrative direct-to-consumer sales a lift.

Paramount鈥檚 Q3 results reflect strong streaming growth: To attain 3.5 million new subscribers and $49 million in DTC profit, it鈥檚 leveraged cost cutting and content innovation to balance revenue pressures from traditional TV.

Senators probe Pfizer, Eli Lilly about their D2C telehealth platforms: But we don鈥檛 expect a slowdown in Big Pharma鈥檚 push into direct-to-consumer sales. Here鈥檚 why.

Insurance agents marked 鈥榮afe鈥� from disruption: The ups and downs of the direct-to-consumer life insurance market have taught the industry a lot about contemporary consumers and in-person experiences.

Volkswagen aims to attract truck buyers with retro-themed Scout SUVs and pickups designed and built in the US.